2-es típusú cukorbetegség: vizsgálatok itt: Szerbia

1 trial · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  Where

  Belgrade, Kamenitz, Kragujevac, Niška Banja, Pančevo

  Életkor

  18 év and over

  People

  11 800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07064473 · EU 2025-521188-11-00